You searched for "treatment"
Elevated prevalence of late-onset dysphagia among head and neck cancer survivors and identifying risk factors
Dysphagia is one of the most common problems affecting head and neck cancer (HNC) survivors. There are few studies investigating late-onset dysphagia post-treatment. The authors set out to investigate the prevalence of dysphagia-related diagnoses and procedures five years’ post-treatment, changes...
Biologicals for severe chronic rhinosinusitis with nasal polyps. Any use?
Recent advances and knowledge of inflammatory endotypes of chronic rhinosinusitis with nasal polyps (CRSwNP) led to introduction of biological agents such as monoclonal antibodies targeting IgE (omalizumab) and Interleukins (ILs) such as IL4R alpha (dupilumab) and IL5. The European Academy...
Gastrostomy tube dependence following TORS
Transoral robotic surgery (TORS) for oropharyngeal squamous cell carcinoma (OPSCC) is now a well-established treatment modality for early (T1-T2) disease. Accumulating evidence suggests that one of its main benefits relative to conventional chemoradiotherapy is superior long-term functional outcome, especially with...
How long after head and neck cancer diagnosis do patients need opioids?
With the advances in the management of head and neck cancer (HNC), patients tend to survive longer after their diagnosis. These people face the burden of chronic pain management which is strongly associated with HNC. A HNC team in Portland...
A systematic review of adjunctive probiotic therapy in the management of chronic rhinosinusitis
It is generally understood that administering substances containing live microbiologically active micro-organisms (probiotics) enhances the treatment of chronic rhinosinusitis. Probiotics manipulate and rebalance the alterations occurring in the local microbiome in chronic rhinosinusitis patients. This results in propagation of healthy...Early detection pathways for congenital cytomegalovirus for infants referred from the newborn hearing screen
This article discusses requirements for an early congenital cytomegalovirus (cCMV) detection pathway to ensure children do not miss out on the opportunity for timely diagnosis and treatment. The pathways described are currently in use in England and apply to well...BAA to host World Congress of Audiology in 2028
The British Academy of Audiology is delighted to have won its bid to host the International Society of Audiology’s World Congress in 2028 (WCA2028). The 38th Congress will be hosted in Edinburgh, 23-26 April 2028.RSM Laryngology & Rhinology: the year ahead
As the president of the RSM’s Laryngology & Rhinology Section for the 2022-23 academic year, my aim is to centre the education programme around our trainees, with a real emphasis on inspiring the future generation of ENT surgeons.38th World Congress of Audiology 2028
With 1,200 delegates expected to attend, it will be a perfect chance to shine the light on UK audiology, with its unique environment with the National Health Service (NHS) providing the world’s largest healthcare service that is free at the point of delivery.Prednisolone and/or acyclovir for Bell’s palsy
Landmark Paper: Sullivan FM, Swan IRC, Donnan PT, et al. Early treatment with prednisolone or acyclovir in Bell’s Palsy. N Engl J Med 2007;357(16):1598-607. Facial nerve paralysis as a consequence of Bell’s palsy can result in devastating long-term effects on...Chronic rhinosinusitis management: back to the future?
Immunology is a dim and distant medical school memory to many ENT surgeons, but the increasingly complex immunology of chronic rhinosinusitis is fascinating (honestly!). Medical management options in CRS no longer just involves saline and steroids, and we need to...
